These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38425104)

  • 1. Aldosterone Effect on Cardiac Structure and Function.
    Al-Hashedi EM; Abdu FA
    Curr Cardiol Rev; 2024; 20(4):e290224227534. PubMed ID: 38425104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone as a Mediator of Cardiovascular Damage.
    Buffolo F; Tetti M; Mulatero P; Monticone S
    Hypertension; 2022 Sep; 79(9):1899-1911. PubMed ID: 35766038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
    Martinez FA
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.
    Young MJ; Funder JW
    J Hypertens; 2002 Aug; 20(8):1465-8. PubMed ID: 12172301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid antagonism and cardiac hypertrophy.
    Nagata K
    Curr Hypertens Rep; 2008 Jun; 10(3):216-21. PubMed ID: 18765093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
    Leopold JA
    Circulation; 2011 Nov; 124(18):e466-8. PubMed ID: 22042931
    [No Abstract]   [Full Text] [Related]  

  • 8. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis.
    Chou CH; Hung CS; Liao CW; Wei LH; Chen CW; Shun CT; Wen WF; Wan CH; Wu XM; Chang YY; Wu VC; Wu KD; Lin YH;
    Cardiovasc Res; 2018 Apr; 114(5):690-702. PubMed ID: 29360942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
    Galuppo P; Bauersachs J
    Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism and cardiac remodeling in ischemic heart failure.
    Fraccarollo D; Galuppo P; Bauersachs J
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):287-94. PubMed ID: 15320779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone in heart failure: pathophysiology and treatment.
    Struthers AD
    Curr Heart Fail Rep; 2004 Dec; 1(4):171-5. PubMed ID: 16036041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone receptor antagonists.
    Azizi M
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):179-181. PubMed ID: 32473789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
    Chabot A; Jiang BH; Shi Y; Tardif JC; Dupuis J
    BMC Cardiovasc Disord; 2011 Dec; 11():72. PubMed ID: 22136321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone, mineralocorticoid receptor, and heart failure.
    Messaoudi S; Azibani F; Delcayre C; Jaisser F
    Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone and end-organ damage.
    Brown NJ
    Curr Opin Nephrol Hypertens; 2005 May; 14(3):235-41. PubMed ID: 15821416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.
    Zannad F; Radauceanu A
    Heart Fail Rev; 2005 Jan; 10(1):71-8. PubMed ID: 15947894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking aldosterone in heart failure.
    Shafiq MM; Miller AB
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.